NASDAQ:RAPT
Delisted

Rapt Therapeutics Stock Signals

etoro logo Buy RAPT
*Your capital is at risk
$58.02
+0 (+0%)
At Close: Jun 01, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for RAPT Therapeutics, Inc.

General

Signal Type Signal Value Data
Score 0.000 93 days ( -65.30 %
Last Price $58.02 0 %
Performance History
7 Days
$58.02 $58.02
0%
30 Days
$58.02 $58.02
0%
12 Mos
$0.89 $58.02
6,453.71%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 25
Signal Type Signal Value Importance Data
High / Low N/A Very Low $58.02 - $58.02
Trend - 3 mos 0 % High Width: 0.0000000000000 %
Pred. range - 3 mos $58.02 - $58.02 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low May 29, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Mar 06, 2026 - 60 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 60.24
Signal Type Signal Value Importance Data
Trend - 12 mos 650.11 % Very High Width: 35.51 %
Pred. range - 12 mos $425.64 - $576.78 High 633.61 % - 894.11 %
Short MA 12 mos Sell Very High Jan 14, 2026 - 95 days
Long MA 12 mos Buy Very High Jun 16, 2025 - 241 days
Short/Long MA 12 mos Buy Very High Jun 16, 2025 - 241 days
Pivot Long Sell Low May 29, 2026 - 2 days
RSI Long Pivot Signal Sell Low Mar 17, 2026 - 53 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT RAPT THERAPEUTICS, INC.
RAPT Therapeutics
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead onco...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE